Glaucoma Flashcards
Which of the following does not describe Glaucoma?
a. it is a group of diseases
b. it is the narrowing of the visual field
c. it is usually secondary to retinal ganglion cell death
d. it is a disease of inclusion
e. leading cause of blindness in African Amer. and Hispanics
d is false. Glaucoma is a disease of EXCLUSION, not inclusion!
Which is not a correct target for glaucoma therapy?
a. decrease aqueous production
b. increase trabecular outflow
c. decrease uveoscleral outflow
c. is incorrect! should be INCREASE uveoscleral outflow.
Which is true?
a. Nicotinic Receptors are postganglionic in the Somatic NS and terminal in the Autonomic NS
b. Muscarinic Receptors are postganglionic in cholinergic systems.
c. NorEpi is the NT in Sympathetic Cholinergic System
d. Muscarinic Receptors are terminal in cholinergic systems.
d. is true!
all the others are false!
-Nicotinic Receptors are postganglionic in the AUTONOMIC system and terminal in the SOMATIC system.
-Muscarinic Receptors are TERMINAL in the cholinergic systems.
-NorEpi is the NT in Sympathetic ADRENERGIC system.
(and ACh is the NT in all the other systems)
Which is not true for ocular pharmacokinetics?
a. tear film –> cornea –> aqueous humor –> iris –> systemic circ.
b. tear film –> cornea –> iris –> aqueous humor –> systemic circ.
c. tear film –> conjunctiva –> systemic circ.
d. tear film –> conjunctiva/sclera –> ciliary body –> systemic circ.
e. tear film –> nasolacrimal duct –> systemic circ.
b. is not true!
T/F: the only 2 that can go directly to systemic circ. from the tear film are conjunctiva and nasolacrimal duct.
true!
+b2 = bronchoDILATION, vasoDILATION, glucogenoLYSIS, INCREASE insulin release, & INCREASE aqueous production.
true. memorize this!
+a2 = INHIBITION of signal propagation, vasoDILATION, DECREASE insulin release & DECREASE aqueous production.
true. memorize this!
- b2 = DECREASE aqueous production
note: there is no -a2.
true!
\+b1 = INCREASE contractility and conduction. \+a1 = vasoCONSTRICTION, mydriasis (dilate), and INCREASE uveoscleral outflow.
true!
epinephrine and dipivephrine are:
a. selective sympathomimetics
b. nonselective sympathomimetics
nonselective sympathomimetics
Receptors for nonselective sympathomimetics are:
a. +b1,+b2, +a1, +a2
b. +a2 and +a1 only.
a. +b1,2 +a1,2
apraclonidine and brimonidine (“onidine” suffix) are:
a. selective sympathomimetics
b. nonselective sympathomimetics
selective
which is more effective?
a. brimonidine
b. apraclonidine
brimonidine, because it effectively decreases aq. production and increases uveoscleral outflow. While apraclonidine only MILDLY decreases aq. production. Also, apraclonidine is not good for long term use, due to risk of tachyphylaxis.
Which are NOT used orally for IOP reduction because they are rapidly metabolized by the 1st pass effect in the liver/intestine?
a. epinephrine and dipivephrine
b. apraclonidine and brimonidine
epinephrine and dipivephrine (nonselective sympathomimetics)
T/F: dipivephrine is a lipophilic pro-drug, meaning it penetrates the corneal epithelium; while epinephrine is a major ocular surface irritant.
True!
If your patient is taking MAOI’s, which glaucoma treatment should NOT be used due to contraindications??
a. CA Inhibitors
b. Hyperosmotic agents
c. Sympathomimetic agents
d. Sympatholytic agents
e. Parasympathomimetic agents
sympathomimetic agents (epinephrine, dipivephrine, apraclonidine, and brimonidine)
T/F: brimonidine has less likelihood of causing tachyphylaxis compared to apraclondine. and it does not cause conjunctival blanching. therefore brimonidine is the better drug.
true!
metipranolol, timolol, betaxolol, carteolol, levobunolol are what kind of glaucoma treatment?
a. Sympatholytic beta blockers
b. Sympathomimetics
c. Parasympathomimetics
d. CA inhibitors
sympatholytic beta blockers (all have “olol” suffix)
which beta blocker targets only the b1 receptor?
a. metipranolol
b. timolol
c. betaxolol
d. levobunolol
e. carteolol
betaxolol
which beta blocker is known to have significant anesthetic effects?
a. metipranolol
b. timolol
c. betaxolol
d. levobunolol
e. carteolol
metipranolol
which beta blocker is NOT good for asthma, but is OK for diabetes, and is a nitric oxide agonist?
a. metipranolol
b. timolol
c. betaxolol
d. levobunolol
e. carteolol
carteolol
which beta blocker is cardio-selective, and is known as the safest beta blocker for asthmatic patients?
a. metipranolol
b. timolol
c. betaxolol
d. levobunolol
e. carteolol
betaxolol
T/F: all the beta blockers used for OAG have extensive first pass metabolism
true
T/F: apraclonidine, a selective sympathomimetic, selects a2 receptor more over a1 compared to brimonidine.
False!
brimonidine is the one that selects a2»_space;> a1
which is NOT an adverse effect of beta blockers?
a. depression
b. sedation
c. tachycardia
d. alopecia
e. corneal anesthesia
c. tachycardia is NOT an adverse effect. bradycardia is!
note: alopecia = hair loss
which of the following are contraindications for beta blocker usage?
a. asthma
b. COPD
c. CHF
d. bradycardia
e. all of the above!
e. all of the above!